Total Payments
$5,657
2024 Payments
$661.63
Companies
45
Transactions
341
Medicare Patients
13,257
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$5,657 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,657 | 341 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $851.65 | 52 | $0 (2024) |
| ABBVIE INC. | $446.69 | 29 | $0 (2024) |
| Astellas Pharma US Inc | $438.59 | 22 | $0 (2024) |
| Novo Nordisk Inc | $392.60 | 24 | $0 (2024) |
| Abbott Laboratories | $346.16 | 17 | $0 (2024) |
| Amgen Inc. | $332.15 | 19 | $0 (2022) |
| PFIZER INC. | $327.33 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $206.60 | 11 | $0 (2023) |
| Boston Scientific Corporation | $206.29 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $179.55 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $661.63 | 33 | ABBVIE INC. ($112.04) |
| 2023 | $747.91 | 39 | Exact Sciences Corporation ($117.21) |
| 2022 | $899.32 | 52 | ABBVIE INC. ($184.23) |
| 2021 | $694.34 | 43 | GlaxoSmithKline, LLC. ($92.63) |
| 2020 | $577.16 | 37 | AstraZeneca Pharmaceuticals LP ($121.97) |
| 2019 | $694.13 | 42 | GlaxoSmithKline, LLC. ($150.79) |
| 2018 | $676.61 | 43 | Astellas Pharma US Inc ($168.48) |
| 2017 | $706.16 | 52 | GlaxoSmithKline, LLC. ($155.09) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Insomnia | ||||||
| 11/12/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Neurology | ||||||
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Biological | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: PAIN | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Biological | ||||||
| 04/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: VACCINES | ||||||
| 04/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Insomnia | ||||||
| 03/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes Care | ||||||
| 02/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Oncology | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: VACCINES | ||||||
| 02/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,897 | 2,243 | $442,641 | $148,286 |
| 2022 | 22 | 3,783 | 5,075 | $840,056 | $311,182 |
| 2021 | 24 | 4,215 | 5,779 | $968,440 | $359,874 |
| 2020 | 24 | 3,362 | 5,481 | $912,535 | $276,443 |
Total Patients
13,257
Total Services
18,578
Medicare Billing
$1.1M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 510 | 764 | $194,871 | $50,856 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 240 | 240 | $62,682 | $28,931 | 46.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 81 | 81 | $58,867 | $22,554 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 62 | $22,487 | $7,276 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 152 | $25,688 | $7,163 | 27.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 96 | 96 | $13,824 | $6,902 | 49.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 46 | 46 | $5,153 | $5,050 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 109 | 109 | $8,420 | $3,153 | 37.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $6,074 | $2,607 | 42.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 240 | 301 | $6,020 | $2,521 | 41.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 88 | 88 | $6,403 | $2,488 | 38.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 53 | 53 | $6,625 | $2,044 | 30.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $6,904 | $1,676 | 24.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 68 | 68 | $2,720 | $1,659 | 61.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 67 | 67 | $3,015 | $1,144 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $6,601 | $1,086 | 16.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 25 | 25 | $3,888 | $838.61 | 21.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 25 | $1,397 | $231.17 | 16.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $1,002 | $107.10 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 595 | 1,359 | $361,684 | $114,562 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 528 | 528 | $148,315 | $65,412 | 44.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 314 | 587 | $91,290 | $30,134 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 258 | 299 | $54,086 | $14,558 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 116 | $41,367 | $14,342 | 34.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 554 | 554 | $22,160 | $13,843 | 62.5% |
About Dr. Brian Dewhirst, MD
Dr. Brian Dewhirst, MD is a Family Medicine healthcare provider based in Johns Island, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316965338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Dewhirst, MD has received a total of $5,657 in payments from pharmaceutical and medical device companies, with $661.63 received in 2024. These payments were reported across 341 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($5,657).
As a Medicare-enrolled provider, Dewhirst has provided services to 13,257 Medicare beneficiaries, totaling 18,578 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Johns Island, SC
- Active Since 07/17/2006
- Last Updated 01/27/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316965338
Products in Payments
- TRELEGY ELLIPTA (Drug) $498.76
- VRAYLAR (Drug) $307.86
- Ozempic (Drug) $230.17
- FREESTYLE LIBRE (Device) $229.86
- ENTRESTO (Drug) $206.60
- Aimovig (Biological) $180.71
- MYRBETRIQ (Drug) $173.74
- FARXIGA (Drug) $164.48
- BREO (Drug) $156.16
- XARELTO (Drug) $142.73
- Cologuard Collection Kit (Device) $131.01
- TOVIAZ (Drug) $125.57
- SHINGRIX (Biological) $123.53
- Kerendia (Drug) $120.74
- TOUJEO (Drug) $118.32
- UBRELVY (Drug) $109.29
- VESICARE (Drug) $109.27
- CHANTIX (Drug) $103.16
- Myrbetriq (Drug) $99.64
- QUVIVIQ (Drug) $99.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Johns Island
Carl Bergren, Md, MD
Family Medicine — Payments: $15,489
Family Medicine $15,489
Todd Davis, Md, MD
Family Medicine — Payments: $6,333
Family Medicine $6,333
Dr. Julia Isom, D.o, D.O
Family Medicine — Payments: $4,835
Family Medicine $4,835
Vanessa Mcpherson, Md, MD
Family Medicine — Payments: $4,425
Family Medicine $4,425
Jeanne Lumpkin, Md, MD
Family Medicine — Payments: $1,427
Family Medicine $1,427
Dr. Sasha Perez, M.d, M.D
Family Medicine — Payments: $822.39
Family Medicine $822.39